TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10147050

Group type: EXPERIMENTAL
Intervention: Cost-saving and cost-containment measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large scale trials
Number of subjects: 0
Study: 3977064

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg orally
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ranitidine 50 mg intravenously
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium citrate 30 ml orally
Number of subjects: 40

Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 40
Study: 29961998

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 1545

Group type: COMPARATOR
Intervention: Glimepiride 1 to 4 mg
Number of subjects: 1545
Study: 26022721

Group type: EXPERIMENTAL
Intervention: on line high efficiency hemodiafiltration (HDF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: high-flux hemodialysis (HD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: both HD and HDF
Number of subjects: 20
Study: 25675992

Group type: EXPERIMENTAL
Intervention: 13.3 mg/24 h rivastigmine patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4.6 mg/24 h rivastigmine patch
Number of subjects: 0
Study: 24257390

Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cisatracurium + Albuterol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Rocuronium + Albuterol
Number of subjects: 25
Study: 20554769

Group type: EXPERIMENTAL
Intervention: Thermostatic mixing valves (TMVs) fitted by a qualified plumber and educational leaflets
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Thermostatic mixing valves (TMVs)
Number of subjects: 124
Study: 19025232

Group type: EXPERIMENTAL
Intervention: Attention Modification Program (AMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention Control Condition (ACC)
Number of subjects: 0
Study: 16511727

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15610805

Group type: EXPERIMENTAL
Intervention: Oral oxytetracycline plus topical placebo
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Oral minocycline plus topical placebo
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Topical benzoyl peroxide plus oral placebo
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Topical erythromycin and benzoyl peroxide in a combined formulation plus oral placebo
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Topical erythromycin and benzoyl peroxide separately plus oral placebo
Number of subjects: 649

Group type: COMPARATOR
Intervention: Minocycline versus oxytetracycline
Number of subjects: 649

Group type: COMPARATOR
Intervention: Combined erythromycin and benzoyl peroxide versus oxytetracycline
Number of subjects: 649

Group type: COMPARATOR
Intervention: Combined erythromycin and benzoyl peroxide versus minocycline
Number of subjects: 649

Group type: COMPARATOR
Intervention: Erythromycin and benzoyl peroxide separately versus combined formulation
Number of subjects: 649

Group type: COMPARATOR
Intervention: Benzoyl peroxide versus oxytetracycline
Number of subjects: 649

Group type: COMPARATOR
Intervention: Benzoyl peroxide versus minocycline
Number of subjects: 649

Group type: COMPARATOR
Intervention: Benzoyl peroxide versus combined formulation
Number of subjects: 649
Study: 11825333

Group type: EXPERIMENTAL
Intervention: Galantamine 16 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Galantamine (both dosages)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 0
Study: 9205760

Group type: EXPERIMENTAL
Intervention: Ebrotidine (150, 300, 400, 500, 600, 800 mg)
Number of subjects: 0
Study: 8182977

Group type: EXPERIMENTAL
Intervention: Outpatient preoperative evaluation
Number of subjects: 355

Group type: COMPARATOR
Intervention: Inpatient preoperative evaluation
Number of subjects: 355
Study: 3062906

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (20 micrograms PGE 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (646.7 micrograms alpha‐cyclodextrin)
Number of subjects: 50
Study: 31917765

Group type: EXPERIMENTAL
Intervention: Double low-dose group (n = 35)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard-dose group (n = 32)
Number of subjects: 67
Study: 28787186

Group type: EXPERIMENTAL
Intervention: Tralokinumab 400 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tralokinumab 800 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27391985

Group type: EXPERIMENTAL
Intervention: Inpatient general psychiatric treatment
Number of subjects: 110
Study: 25590930

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 22459275

Group type: EXPERIMENTAL
Intervention: FKBP5 rs9296158
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: FKBP5 rs9470080
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: FKBP5 rs1360780
Number of subjects: 130
Study: 20459655

Group type: EXPERIMENTAL
Intervention: STAR Educational Program (blended learning intervention)
Number of subjects: 244
Study: 18931495

Group type: EXPERIMENTAL
Intervention: Erosion only (EO) - cola drink 3 times/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Erosion + plaque (EP) - cola drink 3 times/day with plaque
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Erosion + caries (EC) - cola drink 3 times/day + sucrose solution 8 times/day with plaque
Number of subjects: 11

Group type: COMPARATOR
Intervention: Caries only (CO) - sucrose solution 8 times/day with plaque
Number of subjects: 11
Study: 15847192

Group type: EXPERIMENTAL
Intervention: Iloprost (20 microg over 6 hours for 5 consecutive days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Core decompression
Number of subjects: 36
Study: 14744417

Group type: EXPERIMENTAL
Intervention: Freshly prepared patches
Number of subjects: 71

Group type: COMPARATOR
Intervention: Previously prepared and stored patches
Number of subjects: 71
Study: 10977380

Group type: EXPERIMENTAL
Intervention: Health Circle (HC) sessions
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 17
Study: 8677869

Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 25

Group type: COMPARATOR
Intervention: Thermodilution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Direct Fick
Number of subjects: 25
Study: 1804595

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus amikacin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus amikacin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study: 6403546

Group type: EXPERIMENTAL
Intervention: Trivalent oral poliomyelitis vaccine prepared from monkey kidney cells
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Trivalent oral poliomyelitis vaccine prepared from human diploid cells (MRC5)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31576697

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy plus durvalumab and tremelimumab
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy plus durvalumab
Number of subjects: 24
Study: 30032978

Group type: EXPERIMENTAL
Intervention: Urine-based screening with Alere Determine TB-LAM Ag and Xpert assays
Number of subjects: 2574

Group type: COMPARATOR
Intervention: Standard-of-care (no urine testing for tuberculosis)
Number of subjects: 2574

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for CD4 counts less than 100 cells per μL
Number of subjects: 2574

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for severe anaemia
Number of subjects: 2574

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for clinically suspected tuberculosis
Number of subjects: 2574
Study: 26341916

Group type: EXPERIMENTAL
Intervention: Nasogastric tube feeding
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nil per os
Number of subjects: 35
Study: 1442907

Group type: EXPERIMENTAL
Intervention: Localized cold therapy to the cesarean section incision
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine postoperative care
Number of subjects: 62
Study: 22729756

Group type: EXPERIMENTAL
Intervention: Kinetic therapy (KT) using oscillating beds (TryaDyne Proventa, KCI)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 89
Study: 19483641

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation to the dorsolateral prefrontal cortex
Number of subjects: 1

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation to the dorsolateral prefrontal cortex
Number of subjects: 1
Study: 18369092

Group type: EXPERIMENTAL
Intervention: Low-Fructose (0.3 g/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Medium-Fructose (0.5 g/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-Fructose (0.7 g/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-Fructose (0.0 g/min)
Number of subjects: 10
Study: 15787663

Group type: EXPERIMENTAL
Intervention: Pioglitazone up to 45 mg once daily
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Gliclazide up to 160 mg two times daily
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 1270
Study: 12095805

Group type: EXPERIMENTAL
Intervention: pyrimethamine and azithromycin
Number of subjects: 46

Group type: COMPARATOR
Intervention: pyrimethamine and sulfadiazine
Number of subjects: 46
Study: 10844383

Group type: EXPERIMENTAL
Intervention: Functional AV fistula (group 1)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Closed AV fistula (group 2)
Number of subjects: 61
Study: 8960854

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Glibenclamide treatment
Number of subjects: 36
Study: 2013140

Group type: EXPERIMENTAL
Intervention: Early hospital discharge on day 4 after aggressive interventional therapy
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Logistic regression model for predicting absence of late major complications
Number of subjects: 580
Study: 6233635

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 39
Study: 31241756

Group type: EXPERIMENTAL
Intervention: Maltreatment exposure (MACE score of 1 or higher)
Number of subjects: 202

Group type: COMPARATOR
Intervention: No maltreatment exposure (MACE score of 0)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Retrospective self-report of physical maltreatment between ages 3-6
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Retrospective self-report of peer emotional abuse at ages 13-15
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Physical maltreatment at age 4
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Nonverbal emotional abuse at age 13
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Peer emotional abuse at age 6
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Peer emotional abuse at age 13
Number of subjects: 202
Study: 30151823

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 26950475

Group type: EXPERIMENTAL
Intervention: Norethisterone (NETA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tranexamic acid and Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
Number of subjects: 84
Study: 25311285

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET), 50-minute session
Number of subjects: 174

Group type: COMPARATOR
Intervention: Education-only intervention, 15-minute session
Number of subjects: 174
Study: 22882198

Group type: EXPERIMENTAL
Intervention: Local anaesthetic wound infiltration plus patient-controlled opiate analgesia (WI group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Epidural analgesia (EP group)
Number of subjects: 65
Study: 18793813

Group type: EXPERIMENTAL
Intervention: CAS with predilation (n=100)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Direct stenting (DS, n=105)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Direct stenting (DS)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: CAS with predilation
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 205
Study: 21605403

Group type: EXPERIMENTAL
Intervention: Intervention programme to improve adherence to recommendations to reduce the use of urethral catheters
Number of subjects: 2943
Study: 15735106

Group type: EXPERIMENTAL
Intervention: Daily iron supplement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient supplement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly multiple micronutrient supplement with daily placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily placebo supplement
Number of subjects: 0
Study: 12898888

Group type: EXPERIMENTAL
Intervention: Basic dental care interventions focusing on prophylactics, education, and treatment
Number of subjects: 0
Study: 9850354

Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound (QUS) parameters (BUA, SOS, Stiffness)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD) measured by DXA (hip, lumbar spine, whole body)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Body composition (lean tissue and fat mass)
Number of subjects: 24
Study: 7976149

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (0.5 microgram kg‐1 min‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (0.5 or 2.5 micrograms kg‐1 min‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2728925

Group type: EXPERIMENTAL
Intervention: Fluoride and calcitriol
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Fluoride and calcium
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: COMPARATOR
Intervention: Calcitriol alone
Number of subjects: 78
Study: 29684999

Group type: EXPERIMENTAL
Intervention: Nano copper (100 mg/kg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Copper sulfate (CuSO4) (50, 100, and 200 mg/kg/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (normal standard diet)
Number of subjects: 28
Study: 27573786

Group type: EXPERIMENTAL
Intervention: da Vinci Surgical Skills Simulator (dVSSS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard da Vinci (SdV)
Number of subjects: 26
Study: 26111528

Group type: EXPERIMENTAL
Intervention: Maternal and child health (MCH) nurse-designed model for DV screening and care
Number of subjects: 10271

Group type: EXPERIMENTAL
Intervention: MCH nurse-designed model for DV screening and care
Number of subjects: 10271

Group type: COMPARATOR
Intervention: Usual care (government mandated face-to-face DV screening)
Number of subjects: 10271
Study: 23253122

Group type: EXPERIMENTAL
Intervention: Active acupuncture
Number of subjects: 238

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 238

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 238
Study: 20681336

Group type: EXPERIMENTAL
Intervention: Progressive Self‐focus Meditation (weekly 1‐hr. training sessions for 5 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waiting-list Control group
Number of subjects: 42
Study: 19026808

Group type: EXPERIMENTAL
Intervention: Esmolol as first-line antihypertensive medication in the operating room
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Combination of esmolol and sodium nitroprusside (Nipride)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Antihypertensive medications at discharge
Number of subjects: 118
Study: 17217606

Group type: EXPERIMENTAL
Intervention: Annual mammography screening
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Comparison of disease stage in the cohort offered screening
Number of subjects: 6000
Study: 12813334

Group type: EXPERIMENTAL
Intervention: Nonoperative management (NOM)
Number of subjects: 12
Study: 11061200

Group type: EXPERIMENTAL
Intervention: Bone-anchored prostheses
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Socket prostheses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control limbs (contralateral side)
Number of subjects: 32
Study: 8856516

Group type: EXPERIMENTAL
Intervention: Information-based intervention (told not to play with guns)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Access to a parent's firearm
Number of subjects: 48

Group type: COMPARATOR
Intervention: Gun play and handling of firearms in the home
Number of subjects: 48
Study: 1474178

Group type: EXPERIMENTAL
Intervention: 30 mg adinazolam mesylate sustained release tablet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 mg immediate release tablet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 15 mg intravenous adinazolam mesylate
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Elderly subjects
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Elderly volunteers
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: N-desmethyladinazolam
Number of subjects: 36
Study: 6090280

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 40
Study: 30862680

Group type: EXPERIMENTAL
Intervention: FGF19 analog (NGM282)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bariatric surgery
Number of subjects: 0
Study: 29894287

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg before PCI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg before PCI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study: 27688236

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 201
Study: 25157768

Group type: EXPERIMENTAL
Intervention: Motesanib 125 mg plus carboplatin/paclitaxel (Arm A)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo plus carboplatin/paclitaxel (Arm B)
Number of subjects: 360
Study: 22527992

Group type: EXPERIMENTAL
Intervention: Social anxiety disorder patients
Number of subjects: 13

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 13
Study: 20102996

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (individuals of similar gender and age without a clinical history of Lyme disease)
Number of subjects: 230
Study: 18853833

Group type: EXPERIMENTAL
Intervention: Autologous platelet gel (AG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 70
Study: 15837412

Group type: EXPERIMENTAL
Intervention: Whole-body low-dose multidetector row-CT (MDCT)
Number of subjects: 100
Study: 12505103

Group type: EXPERIMENTAL
Intervention: Quetiapine (n = 18)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Haloperidol (n = 17)
Number of subjects: 35
Study: 9888625

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 4 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Triazolam 0.75 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8591350

Group type: EXPERIMENTAL
Intervention: Structured abstracts
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard reporting
Number of subjects: 101
Study: 2507667

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg p.o. plus metoprolol 50 mg p.o.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam 10 mg p.o. plus i.m. scopolamine 0.006 mg/kg and morphine 0.2 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both combinations
Number of subjects: 12
Study: 320090

Group type: EXPERIMENTAL
Intervention: Oestradiol benzoat and hydroxyprogesterone capronat
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo (no hormonal treatment)
Number of subjects: 265
Study: 30638398

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (approximately 10^9 CFU) for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Calorie and protein-appropriate diet for 3 months (Control)
Number of subjects: 100
Study: 27500908

Group type: EXPERIMENTAL
Intervention: Internal Family Systems (IFS) therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Treatment as usual (CBT or IPT)
Number of subjects: 37
Study: 25440273

Group type: EXPERIMENTAL
Intervention: Methylprednisolone at anesthesia induction (30 mg/kg IV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Methylprednisolone by CPB prime (30 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 45
Study: 23895807

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Medical therapy (MT)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Overall mortality (diabetics vs non-diabetics)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Cardiac mortality (diabetics vs non-diabetics)
Number of subjects: 232
Study: 21112742

Group type: EXPERIMENTAL
Intervention: Thymoquinone (1mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 19304555

Group type: EXPERIMENTAL
Intervention: Extended release formulation of tramadol hydrochloride (TRH) based on osmotic technology
Number of subjects: 6

Group type: COMPARATOR
Intervention: Commercial TRH tablets (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Optimized formulation (batch IVB)
Number of subjects: 6